Concepedia

Julian Adams

JA

Statistics

Publications

141

Citations

29.7K

H-Index

73

Active since

1969

Affiliations

University of Michigan(Current)

Millennium Engineering and Integration (United States)

Infinity Pharmaceuticals (United States)

Boehringer Ingelheim (United States)

Dana-Farber Cancer Institute

Julian Adams is an author at University of Michigan specializing in medicine, pharmacology, and life sciences.

ORCID

Publications per year

1969–2024

141

Publications

141

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

Kenneth P. Olive, Michael A. Jacobetz, Christian J. Davidson et al. · Science · 2009 · 3.1K citations · Full text

, , +17

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

, , +10

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Teru Hideshima, Paul G. Richardson, D Chauhan et al. · PubMed · 2001 · 1.5K citations

, , +17

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Julian Adams, Vito J. Palombella, Edward A. Sausville et al. · PubMed · 1999 · 1.5K citations

, , +14

NF-κB as a Therapeutic Target in Multiple Myeloma

Teru Hideshima, Dharminder Chauhan, Paul G. Richardson et al. · Journal of Biological Chemistry · 2002 · 892 citations · Full text

, , +16

1–5 of 141